Researchers chart nearly 25.5 million individual brain cells to create a 3D atlas of the basal ganglia, which plays a key role in movement, habit, and reward. The study reveals that glia change with age more than neurons, and inflammation-associated immune cells increase in many regions.
A new atlas reveals how key human brain cells develop and mature before and after birth, shedding light on cell types linked to schizophrenia and other conditions. The study mapped gene regulation in the developing basal ganglia, a region implicated in Parkinson's disease, Huntington's disease, and addiction.
Gladstone researchers create atlas of proteins transported across blood-brain barrier, revealing its role in delivering beneficial proteins to brain cells. The study suggests that increasing supply of protective proteins like APOA1 can counter signs of Alzheimer's disease, offering new potential treatment strategies.
A new study reveals that the CASS4 gene plays a crucial role in Alzheimer's disease by directing brain-cleaning immune cells, which can be disrupted leading to the buildup of toxic plaques. This discovery offers new hope for the development of treatments or prevention strategies by targeting the gene or microglia in the brain.
Researchers investigate how early inflammation and stress can lead to long-term changes in brain cells, making them more susceptible to Alzheimer's disease. Cellular
Monique Balthazar's $1M NIH grant will investigate how sleep, biological factors, and neighborhood conditions relate to cognitive decline and Alzheimer's disease risk. She will examine lipid metabolism and inflammation, particularly specialized pro-resolving mediators, in the Einstein Aging Study.
The National MS Society is launching a funding opportunity to support innovative screening technologies for early MS detection. The goal is to accelerate progress in identifying individuals at risk of MS, ultimately reducing time to diagnosis and improving long-term outcomes.
A research team identified a signaling pathway involving AQP4, TRPA1, BEST1, and D-serine that helps maintain neuronal activity and cerebral blood-volume responses during prolonged sensory stimulation. Astrocytes release D-serine, which supports neuronal activity and contributes to dilation of brain blood vessels.
A study of 601 participants found that younger patients with Alzheimer's disease have a higher burden of tau protein at disease onset and faster protein buildup, while older patients display different patterns of disease-linked protein accumulation
Researchers at Macquarie University Brain Institute and Clinic helped accelerate search for disease-causing genes by building new genetic families. They identified 793 related pairs, 30% previously unrecognised relationships, and 73 new DNA-based family trees.
Henry Ford Health expands high-intensity focused ultrasound treatment to more patients with Parkinson's disease, targeting symptoms beyond tremor. The procedure, initially launched for essential tremor and tremor-dominant Parkinson's disease, is now available to patients experiencing stiffness, slowed movement, and dyskinesia.
The TAME-Q software standardizes Tau PET image analysis, providing a transparent and reproducible workflow for neurodegenerative disease research. It successfully processed 133 datasets and correlated machine learning-derived tau scores with benchmark scores from previous studies.
A rare case of early-onset Parkinson's disease reveals molecular changes in platelets associated with disease progression. The study identified changes in gene expression in platelets, including those involved in mitochondrial function and protein synthesis, providing insights into molecular processes involved in disease progression.
Researchers propose targeting G protein-coupled receptors to slow aging, exploring AI, systems biology, and digital twins for therapy design. The approach could work alongside senolytic, metabolic, and regenerative strategies.
Researchers propose novel therapies to rebalance GPCR signaling, potentially extending healthy years of life and delaying multiple age-related diseases. This network-level approach could give rise to personalized treatments and complement emerging longevity strategies.
Maladaptive brain-state locking (MBSL) is a lifespan hypothesis suggesting that distinct disorders converge on impaired state-transition or recovery dynamics. Candidate features include abnormal persistence, impaired transition, and delayed recovery, with lifespan timing and regional context modifying phenotypic expression.
A Lehigh-led team is developing an AI platform called UniBrain to simplify brain imaging analysis, reducing the time and expertise required. The platform aims to unify image preprocessing and downstream brain network analysis, integrating information from multiple imaging modalities.
Researchers found that mice genetically engineered to have dementia symptoms who received BCG vaccine showed reduced neurofibrillary tangles, sustained immune cell activation, and memory loss compared to untreated mice. BCG vaccination was also linked to reduced inflammation and improved cognitive function in the mice.
EPND+ builds on five years of public-private collaboration, supporting existing and future research collaborations in neurodegeneration and beyond. The new organization will operate the EPND Hub, providing a unified gateway to valuable research resources, data, and biosamples.
A 16-year study found that older adults with greenery within 100 meters of their homes have a 20% lower risk of developing dementia. The study highlights the importance of preserving and enhancing greenspace in urban environments to support brain health and healthy ageing.
A Johns Hopkins Medicine-led team will build an artificial intelligence model to identify protein misfolding for earlier disease detection and treatment. The goal is to generate tools and resources for clinicians and researchers to diagnose and intervene at earlier stages of neurodegenerative conditions.
A new study found significant disparities in access to anti-amyloid Alzheimer's treatments, with Black adults and Hispanic adults having lower odds of receiving the medication. However, once treatment began, patients were equally likely to take the medication as prescribed, regardless of their race or ethnicity.
Researchers discovered the APOE4 gene variant suppresses Wnt signaling, a key molecular pathway for oligodendrocyte function. The team demonstrates an intervention, GSK3b inhibition, to restore Wnt signaling and myelination, showing potential for preventing Alzheimer's disease.
In a breakthrough, scientists discovered that Alzheimer's disease disrupts the brain's pacemaker cells, causing gamma oscillations to falter. By boosting levels of a specific protein, researchers were able to restore normal brain rhythms and improve cognitive function, offering a promising therapeutic target for the disease.
Researchers have successfully restored the function of neurons linked to cognitive function and information processing in mice with Alzheimer's disease, a breakthrough that could lead to the development of a targeted therapy. The study, published in Neuron, reveals that manipulating parvalbumin interneurons can increase gamma oscillati...
Researchers have developed a new method to deliver disease-fighting antibodies directly to the brain, using extracellular vesicles to bypass the blood-brain barrier. This approach shows potential in treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS, by improving the elimination of pathological proteins.
A new small molecule therapy targets the brain's microglia cells to protect neurons, reducing markers of neuronal damage and inflammatory signaling. The therapy, VG-3927, is well-tolerated and penetrates the central nervous system, reducing levels of a marker of TREM2 in patients with Alzheimer's disease.
Researchers will investigate the role of mitochondrial function in brain health and develop potential treatments for Alzheimer's disease. The study aims to identify biomarkers for mitochondrial health and explore lifestyle strategies to support brain health as people age.
Juvmo, a Parkinson's disease drug, has been approved by the FDA and offers a new treatment option for patients, potentially reducing side effects. The drug's unique mechanism of action provides relief from motor symptoms, and its approval marks a significant milestone in the research of UVA Health scientists.
A large global study of 15,612 adults found that blood biomarker levels varied across racial and ethnic groups, but the relationship between biomarker levels and brain amyloid was generally consistent. The study's findings support the use of blood-based biomarkers to screen for elevated brain amyloid in preclinical Alzheimer's disease ...
A study reveals extensive damage to mitochondrial DNA in vulnerable brainstem neurons, but also identifies a protective response involving the PINK1 gene. This response is more pronounced in individuals who survived longer after their Parkinson's diagnosis.
Researchers have found a new mechanism by which brain immune cells, microglia, protect neurons from Parkinson's disease by removing harmful alpha-synuclein clumps. The study identified a population of activated microglia that can selectively remove pathological protein material from neurons, suggesting a potential therapeutic target fo...
A new study found that the timing of Deep Brain Stimulation (DBS) surgery is critical for preserving cognitive function in Parkinson’s disease patients with a specific genetic mutation. Performing DBS within the first seven to eight years of diagnosis delays significant cognitive decline, while early intervention optimizes physical mob...
Researchers will compare brain cells from women and men with Parkinson's disease to look for biological differences that may explain sex-specific variations in the disease. The study aims to address the underrepresentation of women in Parkinson's research and advance the understanding of the disease's biological underpinnings.
Tau filaments from Alzheimer's disease and vacuolar tauopathy exhibit distinct structural properties, influenced by polyubiquitin post-translational modifications. Shifting polyubiquitin alters filament structures, revealing new insights into tau filament formation and stabilization.
Researchers at the University of Birmingham have identified a critical receptor, P2X7, that drives neuroinflammation in the brain. Blocking this receptor with an existing drug may block pathways to major brain conditions, including Alzheimer's and Parkinson's diseases.
A study analyzing 2,928 Spanish-speaking participants found that machine-learning clocks based on speech can estimate chronological age and brain aging. The speech clock was associated with biological aging, cognitive health, cumulative burden, and dementia.
A study has identified a molecular pathway controlling TFEB activity, revealing new druggable targets for therapies in rare genetic diseases, cancer, and disorders linked to lysosomal dysfunction. Lysosomal stress triggers TFEB activation, which boosts cellular recycling and adapts to stress.
In a mouse study, researchers found that blocking the immune response to tau protein can prevent brain cell death in Alzheimer's disease. By injecting an antibody that blocks CXCR3, they reduced T cell infiltration into the brain, preserving more brain tissue and reducing nerve cell damage. This approach offers a new strategy for treat...
Rutgers engineers have developed a smart shoe that automatically analyzes how a person walks, tracking movement and calories burned with 95.4% accuracy. The prototype powers the analysis with energy generated from the wearer's footsteps, offering a potential solution to the 'energy-intelligence bottleneck' in existing health wearables.
A new review found that insomnia is associated with a 26% higher risk of stroke and 28% higher odds of hospital admission. The study also linked insomnia to depression, suicidal behaviors, and dementia, particularly Alzheimer's disease.
Group 2 innate lymphoid cells (ILC2s) form tight anatomical associations with sensory, autonomic, and enteric nerve fibers, receiving neural regulation through activating and inhibitory pathways. ILC2s also secrete cytokines that can act back on neurons, forming positive feedback loops that modulate allergic and anti-infective immunity.
The Michigan ADRC will support studies on basic science, clinical trials, caregiver interventions, and longitudinal research to advance Alzheimer's disease prevention, treatment, and care. The center aims to fast-track clinical trials and improve the health and well-being of caregivers.
Rima Kaddurah-Daouk named inaugural chair of Precision Behavioral Health, leading global collaboration to advance whole-person health through brain-brain connections. Her research focuses on Alzheimer's disease, metabolic changes, and gut microbiome's role in brain health.
Mount Sinai researchers identified how APOE4 damages brain blood vessels, promoting abnormal protein buildup and neurodegeneration. They found that blocking TGF-β signaling restored pericyte coverage, reducing fibrosis and vascular amyloid accumulation.
A novel research approach, the Law Clinic Study, allows people with dementia to contribute to knowledge, increasing societal understanding and improving future situations. Participants valued being heard and contributing to research, challenging stereotypes that people with dementia are unable to participate.
A new study by UC Berkeley researchers suggests that hyperreactive astrocytes are a primary driver of childhood epilepsy, particularly in the inherited disorder tuberous sclerosis complex. The findings highlight possible therapies to reduce inflammation and alleviate seizures, challenging the traditional view that neurons are the sole ...
A new drug, Kamuvudine K-9, has been shown to preserve nerve fibers and halt neurological damage in a mouse model of multiple sclerosis. The drug, derived from HIV drugs, has been found to be more effective than existing treatments in restoring function and reducing inflammation.
Researchers identified shared and disease-specific molecular changes in human brain tissue, contributing to neurodegeneration, psychiatric illness, and cognitive decline. The collection establishes a foundational resource for understanding brain disorders, accelerating discovery and therapy development.
Researchers at UC San Diego identified a naturally occurring peptide called catestatin (CST) that reduces toxic protein accumulation, neuroinflammation, and improves cognitive function in mouse models. CST may provide a new peptide-based therapeutic strategy for Alzheimer's disease and related neurodegenerative disorders.
This technology enables high-throughput screening for small molecules that selectively lower toxic CAG repeat RNA, helping to develop therapies for neurodegenerative diseases like Huntington’s and spinocerebellar ataxias. The system overcomes major limitations of previous constitutive systems by utilizing an inducible promoter, dual-re...
Researchers identify elevated levels of meprin-β in brain and cerebrospinal fluid of people with Alzheimer's disease, particularly in advanced stages. This finding suggests a possible relationship between meprin-β and beta-amyloid accumulation, a hallmark of the disease.
JMIR Neurotechnology invites submissions on digital health technologies in Parkinson disease, focusing on measurement and intervention. The call for papers aims to address challenges in validation, reproducibility, and clinical integration of these measurements.
The Cleveland Alzheimer’s Disease Research Center will receive funding to accelerate research for Alzheimer’s disease and related dementias. The center aims to understand why dementia progresses at different rates among individuals and across its various forms.
Scientists at Salk Institute create first microprotein atlas of human frontal cortex with and without Alzheimer's disease, identifying 1,067 new microproteins and a potential link to immune cell dysfunction in Alzheimer's. The atlas provides a system for investigating microproteins in aging and neurodegeneration, bringing scientists cl...
A Korea University study investigated plasma p-tau217 as an early marker of treatment response in early Alzheimer's disease. The study found that patients with greater reductions in p-tau217 levels had more favorable cognitive trajectories.
Researchers explore the potential of shadow AI in healthcare, voice analysis for early disease detection, and digital resurrection technologies for bereavement. A recent FDA approval also highlights the therapeutic benefits of video games for ADHD treatment, with potential for personalization and immersion in the future.
A new brain atlas reveals that neurons build their identity in the first hours of life, rather than inheriting it from their parent cells. The atlas, which mapped nearly 250,000 fly brain cells, shows that neuronal identity is established through a flexible, modular system involving different DNA switches and regulatory proteins.
A new study found that aging significantly limits the ability of support cells in the retina to be reprogrammed into new neurons, a discovery that has important implications for the future of regenerative medicine. The study, published in the Proceedings of the National Academy of Sciences, also found that inflammation and decreased ce...
Binghamton University receives $500K grant for 'brain-on-a-chip' project to advance dementia research. The project will establish advanced imaging and electrophysiological analysis infrastructure for studying living brain tissue models.